U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.469G>A (p.Glu157Lys) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
May 13, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000517004.22

Allele description [Variation Report for NM_000162.5(GCK):c.469G>A (p.Glu157Lys)]

NM_000162.5(GCK):c.469G>A (p.Glu157Lys)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.469G>A (p.Glu157Lys)
HGVS:
  • NC_000007.14:g.44150970C>T
  • NG_008847.2:g.52201G>A
  • NM_000162.5:c.469G>AMANE SELECT
  • NM_001354800.1:c.469G>A
  • NM_033507.3:c.472G>A
  • NM_033508.3:c.466G>A
  • NP_000153.1:p.Glu157Lys
  • NP_001341729.1:p.Glu157Lys
  • NP_277042.1:p.Glu158Lys
  • NP_277043.1:p.Glu156Lys
  • LRG_1074t1:c.469G>A
  • LRG_1074t2:c.472G>A
  • LRG_1074:g.52201G>A
  • LRG_1074p1:p.Glu157Lys
  • LRG_1074p2:p.Glu158Lys
  • NC_000007.13:g.44190569C>T
  • NM_000162.3:c.469G>A
  • p.GLU157LYS
Protein change:
E156K
Links:
dbSNP: rs1554335570
NCBI 1000 Genomes Browser:
rs1554335570
Molecular consequence:
  • NM_000162.5:c.469G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.469G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.472G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.466G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000613433Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics criteria)
Pathogenic
(Feb 24, 2021)
unknownclinical testing

PubMed (9)
[See all records that cite these PMIDs]

SCV001794264GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(May 13, 2024)
germlineclinical testing

Citation Link,

SCV002069052Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 21, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002268185Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 25, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents.

Feigerlová E, Pruhová S, Dittertová L, Lebl J, Pinterová D, Kolostová K, Cerná M, Pedersen O, Hansen T.

Eur J Pediatr. 2006 Jul;165(7):446-52. Epub 2006 Apr 7.

PubMed [citation]
PMID:
16602010
See all PubMed Citations (11)

Details of each submission

From Athena Diagnostics, SCV000613433.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

This variant was not reported in large, multi-ethnic, general populations (http://gnomad.broadinstitute.org). This variant has been identified in multiple unrelated individuals with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant displayed altered enzyme kinetics compared to wild type with an increased affinity for glucose, disrupting the normal response. (PMID: 30590153)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV001794264.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 16602010, 14517946, 29056535, 11508276, 30590153, 31216263, 34556497, 20337973, 37292969, 28726111, 35472491, DuzkaleN2023[Article], 24430320)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV002069052.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002268185.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 157 of the GCK protein (p.Glu157Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant maturity onset diabetes of the young (PMID: 11508276, 20337973, 28726111, 29056535, 31216263; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 447402). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GCK protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GCK function (PMID: 30590153). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024